Triple-negative breast cancer (TNBC) is immunohistochemically defined by the lack of three important receptors: estrogen (ER), progesterone (PR) and human epidermal growth factor receptor 2 (HER2) [1, 2]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.